FDA Adverse Event Malfunction Summary report: N

DIMENSION(R) CLINICAL CHEMISTRY SYSTEM

MDR report key: 3143054 · Received June 3, 2013

Report

Report Number
2517506-2013-00212
Event Type
Malfunction
Date Received
June 3, 2013
Date of Event
March 6, 2013
Report Date
May 7, 2013
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Product Code
LCP
PMA / PMN Number
K963498
Removal / Correction Number
2517506-05-17-2013-006-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HEALTHCARE DIAGNOSTICS HAS CONFIRMED COMPLAINTS OF DIMENSION(R) CHEMISTRY WASH CAUSING QC AND PATIENT SAMPLE RESULT SHIFTS. INTERNAL INVESTIGATION HAS CONFIRMED SHIFTS CAN BE ENCOUNTERED IN TWO SCENARIOS: WHEN AN AFFECTED LOT OF CHEMISTRY WASH IS PLACED ON THE INSTRUMENT FOLLOWING AN UNAFFECTED LOT, A NEGATIVE BIAS WILL BE SEEN ON CTNI, LTNI, TSH, PBNP AND LPBN. A POSITIVE BIAS WILL BE SEEN ON FT4. IF ANY OF THESE ASSAYS ARE CALIBRATED USING AN AFFECTED LOT OF CHEMISTRY WASH, QC SHOULD RETURN WITHIN RANGE; BUT WHEN A SUBSEQUENT UNAFFECTED CHEMISTRY WASH LOT IS PLACED INTO USE, A POSITIVE BIAS WILL BE SEEN ON CTNI, LTNI, TSH, PBNP AND LPBN. A NEGATIVE BIAS WILL BE SEEN ON FT4. SIEMENS HEALTHCARE DIAGNOSTICS INC. ISSUED AN URGENT MEDICAL DEVICE CORRECTION LETTER, (B)(4), IN MAY 2013. THE LETTER STATED THAT SIEMENS HAS CONFIRMED THAT CHANGING THE CHEMISTRY WASH LOT CAN CAUSE QC AND PATIENT SAMPLE RESULT SHIFTS. THE LETTER DIRECTED CUSTOMERS TO DISCONTINUE USE AND DISCARD REMAINING INVENTORY OF THE FOLLOWING LOTS OF CHEMISTRY WASH: RD23031, RD23111, RD23241, RD23311, RD23391, AND RD23461. THE LETTER ADVISED CUSTOMERS TO ENSURE CTNI, LTNI, TSH, FT4, PBNP AND/OR LPBN ASSAYS HAVE BEEN CALIBRATED USING AN UNAFFECTED LOT OF CHEMISTRY WASH.

Description of Event or Problem · 1

A CUSTOMER COMPLAINS OF QC SHIFTS WITH FREE THYROXIN (FT4) AND THYROID STIMULATING HORMONE (TSH) WITH LOT RD23031 OF DIMENSION(R) CHEMISTRY WASH. IT IS UNKNOWN IF PATIENT RESULTS WERE REPORTED TO THE PHYSICIANS WHILE QC WAS OUT OF RANGE. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE SHIFTS IN TSH & FT4 RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
245044 DIMENSION(R) CLINICAL CHEMISTRY SYSTEM CHEMISTRY WASH LCP SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW RD23031

Patients

Seq Age Sex Outcome Treatment
1